Emergent BioSolutions Files Q1 2025 10-Q
Ticker: EBS · Form: 10-Q · Filed: May 8, 2025 · CIK: 1367644
| Field | Detail |
|---|---|
| Company | Emergent Biosolutions Inc. (EBS) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Emergent BioSolutions dropped its Q1 2025 10-Q. Check financials.
AI Summary
Emergent BioSolutions Inc. filed its quarterly report for the period ending March 31, 2025. The company's financial statements and disclosures for the first quarter of 2025 are presented. Key financial data and business operations are detailed within this 10-Q filing.
Why It Matters
This filing provides investors and stakeholders with the latest financial performance and operational updates for Emergent BioSolutions, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: medium — 10-Q filings are standard disclosures, but the specific financial health and operational details within can reveal significant risks or opportunities.
Key Numbers
- 2025 Q1 — Reporting Period (First quarter of 2025)
- 12/31 — Fiscal Year End (Company's fiscal year end date)
Key Players & Entities
- Emergent BioSolutions Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250508 (date) — Filing date
- 240-631-3200 (phone_number) — Company business phone
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted on May 8, 2025.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0001367644.
What is the business address of Emergent BioSolutions Inc.?
The business address is 300 PROFESSIONAL DR, GAITHERSBURG, MD 20879.
What is the Standard Industrial Classification (SIC) code for Emergent BioSolutions Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Emergent BioSolutions Inc. (EBS).